Literature DB >> 15003016

Acid- and salt-triggered multifunctional poly(propylene imine) dendrimer as a prospective drug delivery system.

Constantinos M Paleos1, Dimitris Tsiourvas, Zili Sideratou, Leto Tziveleka.   

Abstract

A novel dendrimeric compound is designed with the objective of simultaneously addressing issues commonly encountered in drug delivery, i.e., stability in biological milieu as well as targeting. For this purpose, a multifunctional dendrimeric system derived from diaminobutane poly(propylene imine) dendrimers (DAB) is prepared bearing at its external surface poly(ethylene glycol) chains and guanidinium moieties. For these moieties, it has been established that they exhibit protective and targeting properties, respectively. The release of encapsulated compounds is triggered by titration with acids followed by the addition of sodium chloride solution. Specifically for pyrene, the solubilization site of which can be clearly traced, protonation leads to a distribution between the core and the poly(ethylene glycol) chains in the periphery of the dendrimer while it is released to the aqueous bulk solution by the addition of sodium chloride. The release of betamethasone valerate is also triggered by the addition of sodium chloride solution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15003016     DOI: 10.1021/bm030068h

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  11 in total

1.  Dendrimeric micelles for controlled drug release and targeted delivery.

Authors:  Ashootosh V Ambade; Elamprakash N Savariar; S Thayumanavan
Journal:  Mol Pharm       Date:  2005 Jul-Aug       Impact factor: 4.939

Review 2.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

3.  Amino acid-functionalized dendrimers with heterobifunctional chemoselective peripheral groups for drug delivery applications.

Authors:  Raghavendra S Navath; Anupa R Menjoge; Bing Wang; Roberto Romero; Sujatha Kannan; Rangaramanujam M Kannan
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

4.  Gold nanoparticle-DNA aptamer-assisted delivery of antimicrobial peptide effectively inhibits Acinetobacter baumannii infection in mice.

Authors:  Jaeyeong Park; Eunkyoung Shin; Ji-Hyun Yeom; Younkyung Choi; Minju Joo; Minho Lee; Je Hyeong Kim; Jeehyeon Bae; Kangseok Lee
Journal:  J Microbiol       Date:  2021-12-29       Impact factor: 3.422

5.  Synthesis of New Functionalized Citric Acid-based Dendrimers as Nanocarrier Agents for Drug Delivery.

Authors:  Hassan Namazi; Sanaz Motamedi; Mina Namvari
Journal:  Bioimpacts       Date:  2011-06-09

Review 6.  Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.

Authors:  Vladimir Torchilin
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

7.  Gold nanoparticles - the theranostic challenge for PPPM: nanocardiology application.

Authors:  Mykola Ya Spivak; Rostyslav V Bubnov; Ilya M Yemets; Liudmyla M Lazarenko; Natalia O Tymoshok; Zoia R Ulberg
Journal:  EPMA J       Date:  2013-06-24       Impact factor: 6.543

8.  Development and testing of gold nanoparticles for drug delivery and treatment of heart failure: a theranostic potential for PPP cardiology.

Authors:  Mykola Ya Spivak; Rostyslav V Bubnov; Ilya M Yemets; Liudmyla M Lazarenko; Natalia O Tymoshok; Zoia R Ulberg
Journal:  EPMA J       Date:  2013-07-29       Impact factor: 6.543

Review 9.  Mechanisms and implications of dual-acting methotrexate in folate-targeted nanotherapeutic delivery.

Authors:  Pamela T Wong; Seok Ki Choi
Journal:  Int J Mol Sci       Date:  2015-01-13       Impact factor: 5.923

Review 10.  Advanced Analgesic Drug Delivery and Nanobiotechnology.

Authors:  Nicoleta Stoicea; Juan Fiorda-Diaz; Nicholas Joseph; Muhammad Shabsigh; Carlos Arias-Morales; Alicia A Gonzalez-Zacarias; Ana Mavarez-Martinez; Stephen Marjoribanks; Sergio D Bergese
Journal:  Drugs       Date:  2017-07       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.